| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetes | |||||
| Proteinuria | |||||
| 2 | More general conditions related to this trial | ||||
| Signs and Symptoms | |||||
| Urination Disorders | |||||
| Urologic Diseases | |||||
| Urological Manifestations | |||||
| 3 | Interventions listed in this trial | ||||
| N-acetylcysteine(Mucomyst) | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Acetylcysteine | |||||
| N-monoacetylcystine | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Antidotes | |||||
| Antioxidants | |||||
| Antiviral Agents | |||||
| Expectorants | |||||
| Free Radical Scavengers | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Respiratory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Department of Veterans Affairs | |||||
| West Virginia University | |||||
|
